Trial of mFOLFOX6 + Trastuzumab + Avelumab in Gastric and Esophageal Adenocarcinomas
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03783936 |
|
Recruitment Status : Unknown
Verified May 2021 by Autumn McRee, MD, Hoosier Cancer Research Network.
Recruitment status was: Active, not recruiting
First Posted : December 21, 2018
Last Update Posted : May 12, 2021
|
Sponsor:
Autumn McRee, MD
Collaborators:
EMD Serono
University of North Carolina, Chapel Hill
Information provided by (Responsible Party):
Autumn McRee, MD, Hoosier Cancer Research Network
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Unknown |
|---|---|
| Actual Primary Completion Date : | September 11, 2020 |
| Estimated Study Completion Date : | January 2022 |